ECTRIMS day one: refining multiple sclerosis diagnosis using MRI
A highly detailed 3D rendering of a double helix human DNA in blue color, with small carbon elements and light effects on a dark gray-blue background. The image shows an angle of view of different
Earlier this year, the Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) network published research in The Lancet Neurology, regarding a revision of guidelines for clinicians utilizing MRI scans when diagnosing early stage patients for MS. During the first day of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress, Paolo Preziosa (Vita-Salute San Raffaele University, Milan, Italy) presented the outlines of these results and demonstrated the potential capacity to utilize MRI scans to accurately diagnose individuals with few clinical signs of MS. MRI has been routinely utilized as a diagnostic tool for MS since 2001. Within the...
